- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 70.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 66.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 52.58M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6.55M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.83M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$10.56M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $160K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $62.05M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $63.9M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $48.8M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $38.73M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.89M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$321.14M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$306.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$280.7M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$263.93M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $396.25M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $371.26M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $34.69M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $26.87M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $270.33M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $259.84M |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $259.84M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.47 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.47 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.09M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $10.48M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$21.71M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$24.53M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.34M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$15.56M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.76M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$5.08M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $51.86M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $47.97M |